RESUMEN
Crossed-grating phase-shifting profilometry (CGPSP) has great utility in three-dimensional shape measurement due to its ability to acquire horizontal and vertical phase maps in a single measurement. However, CGPSP is extremely sensitive to the non-linearity effect of a digital fringe projection system, which is not studied in depth yet. In this paper, a mathematical model is established to analyze the phase error caused by the non-linearity effect. Subsequently, two methods used to eliminate the non-linearity error are discussed in detail. To be specific, a double five-step algorithm based on the mathematical model is proposed to passively suppress the second non-linearity. Furthermore, a precoding gamma correction method based on probability distribution function is introduced to actively attenuate the non-linearity of the captured crossed fringe. The comparison results show that the active gamma correction method requires less fringe patterns and can more effectively reduce the non-linearity error compared with the passive method. Finally, employing CGPSP with gamma correction, a faster and reliable inverse pattern projection is realized with less fringe patterns.
RESUMEN
A retrospective cross-sectional study was conducted to assess the frequency of low-dose dexamethasone suppression test (LDDST) patterns in canine patients that had clinicopathologic signs consistent with Cushing's syndrome (CS). Medical records for patients of interest (N = 128) were reviewed between January 2014 and December 2020 to analyse and classify LDDST results based upon the following patterns: lack of suppression, partial suppression, complete suppression, escape, or inverse. Complete suppression, lack of suppression, partial suppression, escape, and inverse patterns were identified in 39.1%, 31.2%, 14.1%, 10.1% and 5.5% of cases respectively. LDDST results were also evaluated with respect to clinical signs, serum alkaline phosphatase (ALP) activity, urine specific gravity (USG) and adrenal ultrasonographic findings. There was no association between LDDST patterns and clinical signs (p = 0.11), increased ALP (p = 0.32), USG (p = 0.33) or adrenal ultrasonographic findings (p = 0.19). In all dogs that demonstrated complete suppression or an inverse pattern, CS was excluded by the attending clinician. The diagnosis of CS was also excluded without further exploration in 23.1%, 7.5% and 5.6% of dogs that demonstrated an escape pattern, lack of suppression and partial suppression pattern, respectively. These results suggest that the clinical significance of LDDST patterns, particularly escape and inverse patterns, are misunderstood by some clinicians, leading them to prematurely exclude the diagnosis of CS.
Asunto(s)
Síndrome de Cushing , Dexametasona , Enfermedades de los Perros , Perros , Animales , Estudios Retrospectivos , Enfermedades de los Perros/diagnóstico por imagen , Síndrome de Cushing/veterinaria , Síndrome de Cushing/patología , Dexametasona/administración & dosificación , Dexametasona/farmacología , Masculino , Estudios Transversales , Femenino , Ultrasonografía/veterinariaRESUMEN
BACKGROUND: The low-dose dexamethasone suppression test (LDDT) is considered an accurate screening and valuable differentiation test in dogs with suspected hyperadrenocorticism (HAC). A recent study showed that the different response patterns not only provide complementary information about etiology, but also the probability of HAC in these patients. OBJECTIVES: We aimed to determine the diagnostic test performance of LDDT response patterns in a population of dogs from an animal hospital. METHODS: The electronic database was retrospectively searched for dogs suspected of HAC that were given an LDDT. Dogs with acute non-adrenal illnesses during the test were excluded. Response patterns were classified as complete suppression, lack of suppression, partial suppression, escape, inverse, and increasing patterns. Cortisol concentrations ≥ 27.59 nmol/L (≥1 µg/dL) 8 hours after dexamethasone administration were considered positive results irrespective of the patterns observed. Calculations included likelihood ratios (LRs) and predictive values (PVs). RESULTS: HAC and non-adrenal illness were diagnosed in 115 (54%) and 62 (46%) dogs, respectively. The positive (+) LRs (95% CI) for the lack of suppression, partial suppression, escape, and an inverse pattern to diagnose HAC were infinite, 8.09 (2-32.72), 3.23 (0.75-14), and 0.2 (0.06-0.73), respectively. CONCLUSIONS: The study confirms that the "lack of suppression" pattern strongly supports a diagnosis of HAC. It shows that the "partial suppression" pattern moderately increases, and the "inverse" pattern decreases the likelihood of HAC. The fact that the study found no association between the "escape" pattern and a diagnosis of HAC, does not support its integration into decision making.
Asunto(s)
Hiperfunción de las Glándulas Suprarrenales , Enfermedades de los Perros , Hiperfunción de las Glándulas Suprarrenales/diagnóstico , Hiperfunción de las Glándulas Suprarrenales/veterinaria , Hormona Adrenocorticotrópica , Animales , Dexametasona , Enfermedades de los Perros/diagnóstico , Perros , Hidrocortisona , Estudios RetrospectivosRESUMEN
BACKGROUND: As the malignant tumor, pancreatic cancer with a meager 5-years survival rate has been widely concerning. However, the molecular mechanisms that result in malignant transformation of pancreatic cells remain elusive. AIM: To investigate the gene expression profiles in normal or malignant transformed pancreas development. METHODS: MaSigPro and ANOVA were performed on two pancreas development datasets downloaded from the Gene Expression Omnibus database. Six pancreatic cancer datasets collected from TCGA database were used to establish differentially expressed genes related to pancreas development and pancreatic cancer. Moreover, gene clusters with highly similar interpretation patterns between pancreas development and pancreatic cancer progression were established by self-organizing map and singular value decomposition. Additionally, the hypergeometric test was performed to compare the corresponding interpretation patterns. Abnormal regions of metabolic pathway were analyzed using the Sub-pathway-GM method. RESULTS: This study established the continuously upregulated and downregulated genes at different stages in pancreas development and progression of pancreatic cancer. Through analysis of the differentially expressed genes, we established the inverse and consistent direction development-cancer pattern associations. Based on the application of the Subpathway-GM analysis, we established 17 significant metabolic sub-pathways that were closely associated with pancreatic cancer. Of note, the most significant metabolites sub-pathway was related to glycerophospholipid metabolism. CONCLUSION: The inverse and consistent direction development-cancer pattern associations were established. There was a significant correlation in the inverse patterns, but not consistent direction patterns.